Member Info for zebbo

More evidence that AGL is shaping up as a one stop platform. Massive cost savings for Oncology throughout

All assets are getting sold off, just happens to be CEYs turn today

Looks like there are a number of job openings on their web site. My guess is they have been holding back until FDA approval. I expect to see greater sales going through 6 months out.
Also hoping that in the background AN and have team have been getting some partnerships lined up. These are key IMO to getting mass market adoption with the right commercials. The market is just so vast.

I expect another deal in Uganda in the next 3-6 months

1. Dont panic. Look through the current SP downdraft - FDA hurdle is done and the Tech unique
2. Commercial model will evolve over the coming months
3. Short term traders will be looking to call lower
4. Funding will only be required to scale. Why do you need to scale....you got it, sales pipeline

Sort of correlates with what heard on CNBC, shipping costs down 26% since Sept 21

Buying by me today and many others by the looks of it. SP is a sham. Shorts on notice we are about to go private ;-)

This is the best BB ever...

When AN talks about shareholders, he generally referring to IIs not PIs. Some people seem to think he has a downer on PI and taking it all to personally . Storm in a teacup IMO

BTW some good level headed posts on the "other site"

looks like the MMs have done their job well.
Hands up who bought high and sold low....

Glad to hear it. I for one will sleep better tonight knowing that..:-))

Okay, I think some people need to ask why they bought AGL in the first place, was it for revenue or potential
For me its potential, however I do want to see a clear path to commercialization and what that entails

The company must value their shareholder base. They must remember they are where they are because of shareholders. We invest for profit, do we not

Boo may surprise us.....

in low volume, profit to bag and up we go

seems like the jury is out on that score. Personally I want to see sizable contracts landed, not hot air

prior to results = back to 90s

what worries me most is that sales failed to take off even prior to FDA in the EU & UK. That is unlikely to change IMO. So although the US is seen as our target market, we have have a lot to prove sales wise, regardless of how good the tech is. Perhaps some medical institutions prefer alternative or different approaches. Just dont understand why we are not turning over 00s, 000s of £M or have orders of that magnitude in the pipeline.

Yep looks like strength is being sold into.
Lets hope our largest shareholders dont decide to cash a few in

I read Q3, no date other than that. Happy for someone to point to a more specific date

Dont forget that SQZ also have £400M in the bank